Dr. Mary E. Gordinier, MD

Dr. Gordinier practices at Norton Women's and Children's Hospital-Operating Room - HOPD in Louisville, Kentucky.

Dr. Gordinier's NPI, 1639192297, was assigned on July 25, 2006. Dr. Gordinier graduated from University of Louisville School of Medicine in 1991. Dr. Gordinier holds Kentucky license 39607.

Dr. Gordinier's primary practice is Norton Women's and Children's Hospital-Operating Room - HOPD, at 4001 Dutchmans Ln, Louisville, KY 40207.

Dr. Gordinier's primary practice is Norton Women's and Children's Hospital-Operating Room - HOPD in Louisville, Kentucky. Dr. Gordinier is also affiliated with Norton Hospital. The medical group on file is Norton Cancer Institute. Dmand AI also links Dr. Gordinier to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gordinier practices, 4 sites in all. Vendor and product names are available with a free account.

Gynecologic oncology is Dr. Gordinier's primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dr. Gordinier is licensed in Kentucky.

CMS data shows 190 Medicare services from Dr. Gordinier across 4 procedure codes in 2024, for 106 Medicare patients. Medicare paid $19,696 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 106 Medicare patients who saw Dr. Gordinier in 2024. The largest group is 65 to 74, with 55 patients. 75% of them have high blood pressure, and 59% have high cholesterol. Their average risk score is 1.99, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gordinier's median patient age at 64, with 100% women.

In 2024, Dr. Gordinier wrote 360 Medicare Part D claims for 86 patients. 93% of them were for generic drugs. CMS names the drug for 258 of them, across 12 drugs with 11 or more claims each, at $4,848 in total drug cost. In 2023, CMS named 194 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Gordinier for performance year 2024, reported as part of a group. Dr. Gordinier accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Removal of the uterus: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 8 papers to Dr. Gordinier, published from 2011 to 2024. 2018 was the busiest year, with 2. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Ovarian Neoplasms and Paclitaxel. Dr. Gordinier has published most often in Gynecol Obstet Invest. Dr. Gordinier's most frequent co-authors are Carol Aghajanian, MD, Cibi Arumugam, MD and Ronald J. Buckanovich.

Dmand AI links Dr. Gordinier to 10 clinical trials, 7 of them phase 3 studies. 3 are still active or recruiting. Conditions studied include Fallopian Tube Diseases, Carcinoma, Ovarian Epithelial and Uterine Cervical Neoplasms. ImmunoGen, Inc. sponsors the most, 2.

CMS Open Payments shows 47 general payments to Dr. Gordinier from 14 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 74% of the total. Intuitive Surgical, Inc. paid the most, $1,031.

Dr. Gordinier graduated from University of Louisville School of Medicine in 1991.